Elritercept
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Elritercept, covering 2026-02-05 to 2026-03-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions [Phase 3]